Dejun Luo Selected Research

Spinal Cord Injuries (Spinal Cord Injury)

1/2020	Retraction notice to "The comparative study of clinical efficacy and safety of baclofen vs tolperisone in spasticity caused by spinal cord injury" [Saudi Pharm. J. 25 (2017) 655-659].
5/2017	The comparative study of clinical efficacy and safety of baclofen vs tolperisone in spasticity caused by spinal cord injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dejun Luo Research Topics

Disease

2	Inflammation (Inflammations) 01/2023 - 10/2022
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 05/2017
1	Osteoarthritis 01/2023
1	Intervertebral Disc Displacement (Herniated Disc) 01/2022
1	Pain (Aches) 01/2022
1	Necrosis 11/2010

Drug/Important Bio-Agent (IBA)

2	Dinoprostone (PGE2)FDA Link 10/2022 - 01/2022
2	TolperisoneIBA 01/2020 - 05/2017
2	Baclofen FDA LinkGeneric 01/2020 - 05/2017
1	nardosinoneIBA 01/2023
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2022
1	polydatinIBA 10/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022
1	Interleukin-6 (Interleukin 6)IBA 10/2022
1	CateninsIBA 10/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2022
1	Serotonin (5 Hydroxytryptamine)IBA 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 11/2010
1	SteroidsIBA 11/2010
1	Escherichia coli endotoxinIBA 11/2010
1	osteokingIBA 11/2010

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2022
1	Moxibustion 01/2022